Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

To prevent implementation of the model, ACCC joined with the Global Colon Cancer Association, the National Infusion Center Association, and the Pharmaceutical Research and Manufacturers of America to file a lawsuit against the U.S. Department of Health and Human Services, seeking an immediate injunction to prevent the implementation of the MFN model.
In the current transition to value-based care, avoidable ER utilization represents an opportunity for cost savings, but difficulties remain in determining what visits are and are not avoidable based on coding and billing data alone.
The Centers for Medicare & Medicaid Services and the American Medical Association finalized its coding updates for CY 2021.
In this article, we describe patients’ perspectives on participation in CCDR studies based on feedback and comments received from patients during our research. Insights reveal the importance and enthusiasm for CCDR studies expressed by patients, and their perspectives on these studies will inform future research and clinical practice toward high quality, patient-centered care delivery.
The issue of drug waste is nothing new in oncology. Drug vial optimization has been shown to be effective in using valuable medications that would otherwise have been wasted.
On Dec. 1, 2020, the Centers for Medicare & Medicaid Services CMS) issued the final rule for the Medicare Physician Fee Schedule (PFS) for CY 2021.
more online @ accc-cancer.org fast facts Financial Advocacy Network Annual Summit ICYMI: This webinar series is now available on demand. Topics include: Promoting Discussions of Cost with Newly Diagnosed Patients, Tracking Financial Assistance Benefits with Dedicated EHR Workflows, Monitor Your Revenue Cycle with a Fiscal Watchdog, Navigating the Unique Financial Challenges of Radiation …
Since those early days so much has changed in our world. The COVID-19 pandemic led to unprecedented challenges, both within the healthcare industry and the world at large. Though we have witnessed much unrest, we have already made it through some very difficult times with stories of great heroism and innovation, especially within the healthcare industry.
In the final installment of ACCC’s webinar series honoring American Pharmacists Month, experts discussed the integral role pharmacists play in supporting clinical trial research in the community setting, and they identified opportunities for extending the pharmacist role in an increasingly complex research landscape.
Explore the barriers and challenges that LGBTQ+ patients with cancer face, and how cancer programs can make their care more inclusive.
January 9, 2021
Speakers discuss several aspects of caregiver engagement, including tools and strategies cancer team members can use to assess and engage caregivers and legal concerns and implications for teams working with caregivers.
Research Review January 2021 Integrating the Community Voice to Advance Cancer Research: A Message from the President’s Task Force By Karen Winkfield, MD, PhD Karen Winkfield, MD, PhD, is a nationally recognized expert in community engagement with cancer clinical research with a focus on programs aimed at reducing disparities in health outcomes for racial and ethnic minorities …
Learn how the American Board of Internal Medicine is urging physicians to publicly share their COVID-19 vaccinations on social media to promote the importance of vaccination.
Rockville, MD – The Association of Community Cancer Centers (ACCC) announced today the addition of Kristin Ferguson, DNP, RN, OCN as Senior Director, Cancer Care Delivery and Health Policy. Ferguson will lead the organization’s initiatives to improve cancer care delivery across rural, urban, and under-resourced settings, and will also provide support and resources to members of the oncology …
Washington, D.C. (December 30, 2020)—On December 28, 2020, a second federal court blocked implementation of the Most Favored Nation (MFN) Model. This order, issued in response to a suit filed by the California Life Sciences Association (CLSA), the Biotechnology Innovation Organization (BIO), and other organizations, prevents the Centers for Medicare & Medicaid Services (CMS) from implementing …
At the risk of repeating a phrase that has been exhausted this year, the dawn of 2020 brought with it unprecedented times. Whereas a pandemic on its own would have dominated everything else, this year also brought on an economic depression; a racial awakening; record-breaking wildfires, hurricanes, and floods; political turmoil on an extraordinary scale; and a host of additional unique phenomena. …
On this episode of CANCER BUZZ, we discuss how healthcare providers and policymakers can work together to pave the future of telehealth beyond the current public health emergency.
1801 Research Blvd. Rockville, MD 20850 Phone: 301.984.9496 | Fax: 301.770.1949 Mailing Lists: ACCC Membership information is provided only for specific one-time use under the terms and conditions outlined in the ACCC One-time User Agreement. ACCC does NOT provide fax numbers or e mail addresses. Format: MS Excel spreadsheet via Email Counts: The number in each list is approximate since …
Washington, D.C. (December 28, 2020)—The Association of Community Cancer Centers (ACCC) celebrates the inclusion of the CLINICAL TREATMENT Act (H.R. 913) and the delay in implementation of the Radiation Oncology (RO) Model to January 1, 2022 in the recent year-end funding bill. The large omnibus bill, signed by President Trump yesterday, allows clinical trials to now be an option for many patients …
Washington, D.C. (December 23, 2020)— A federal court issued a temporary restraining order (TRO) blocking the Center for Medicare & Medicaid Services from implementing its Most Favored Nation (MFN) Interim Final Rule on January 1, 2021. The TRO is part of a lawsuit filed December 4, 2020 by the Association of Community Cancer Centers (ACCC), the Pharmaceutical Research and Manufacturers of America …